Jupiter Life Line Hospitals (JLHL) Q3 24/25 earnings summary

Executive summary

• Announced acquisition of a two-acre plot in Mira Road/Mira-Bhayandar for a new 300-bed multi-specialty hospital, marking the sixth facility and third in the MMR region.

• Construction for the second Pune hospital (Bibvewadi) to begin in March 2025, with the first phase operational by 2028.

• Indore hospital added 78 new beds, increasing capacity to 309, completed ahead of schedule.

• Dombivli hospital's first phase expected to be operational by Q1 FY27.

• Unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, were approved by the Board on February 7, 2025.

Financial highlights

• Q3 FY25 consolidated income: ₹3,206.38 million, up from ₹2,726.13 million in Q3 FY24; nine-month consolidated revenue: ₹9,303.41 million, up from ₹7,790.11 million year-over-year.

• Q3 FY25 consolidated net profit: ₹525.14 million, up from ₹436.67 million in Q3 FY24; nine-month consolidated net profit: ₹1,486.27 million, up from ₹1,313.47 million year-over-year.

• Q3 FY25 EBITDA: ₹76.4 crores, up 21.5% year-over-year; EBITDA margin at 23.7%.

• 9M FY25 total income: ₹934.8 crores, up 19.5% year-over-year; EBITDA: ₹218.3 crores, up 22%; PAT: ₹148.6 crores, up 13.2%.

• Gross profit margin for 9MFY25 was 81.9%; EBITDA margin at 23.4%; PAT margin at 15.9%.

Outlook and guidance

• Construction of the second Pune hospital to begin in March 2025; Dombivli hospital phase 1 to be operational by Q1 FY27.

• Mira Road hospital planned for 2029 completion.

• New greenfield hospitals expected to be EBITDA negative in year one, break-even in year two, and positive in year three.

• Expansion aligns with the medium-term goal of a 2,500-bed network, with continued focus on Western India.